Hematologic changes in a patient with heparin-induced thrombocytopenia who underwent cardiopulmonary bypass after ancrod defibrinogenation.
作者信息
Spiess B D, Gernsheimer T, Vocelka C, Chandler W L, Benak A, Joy J V, Wright I, Hofer B O
机构信息
Department of Anesthesia, University of Washington, Seattle 98195, USA.
出版信息
J Cardiothorac Vasc Anesth. 1996 Dec;10(7):918-21. doi: 10.1016/s1053-0770(96)80057-7.
PMID:8969402
Abstract
摘要
相似文献
1
Hematologic changes in a patient with heparin-induced thrombocytopenia who underwent cardiopulmonary bypass after ancrod defibrinogenation.在进行安克洛酶去纤维蛋白原处理后接受体外循环的肝素诱导的血小板减少症患者的血液学变化。
J Cardiothorac Vasc Anesth. 1996 Dec;10(7):918-21. doi: 10.1016/s1053-0770(96)80057-7.
2
Cardiopulmonary bypass with danaparoid sodium and ancrod in heparin-induced thrombocytopenia.达那肝素钠和安克洛酶在肝素诱导的血小板减少症中的体外循环应用
Ann Thorac Surg. 1998 Aug;66(2):567-9. doi: 10.1016/s0003-4975(98)00511-6.
3
Ancrod anticoagulation for cardiopulmonary bypass in heparin-induced thrombocytopenia and thrombosis.安克洛酶用于肝素诱导的血小板减少症和血栓形成患者体外循环时的抗凝治疗。
Ann Thorac Surg. 1989 Nov;48(5):712-3. doi: 10.1016/0003-4975(89)90800-x.
4
Normal activated clotting time despite adequate anticoagulation with ancrod in a patient with heparin-associated thrombocytopenia and thrombosis undergoing cardiopulmonary bypass.在一名患有肝素相关性血小板减少症和血栓形成且正在接受体外循环的患者中，尽管使用安克洛进行了充分抗凝，但活化凝血时间仍正常。
Anesthesiology. 1994 Mar;80(3):686-8. doi: 10.1097/00000542-199403000-00029.
5
Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
Methods Mol Med. 2004;93:61-82. doi: 10.1385/1-59259-658-4:61.
6
Ancrod: the use of snake venom in the treatment of patients with heparin-induced thrombocytopenia and thrombosis undergoing coronary artery bypass grafting: nursing management.安克洛酶：蛇毒在接受冠状动脉旁路移植术的肝素诱导的血小板减少症和血栓形成患者治疗中的应用：护理管理
Heart Lung. 1996 Nov-Dec;25(6):451-60; quiz 461-2. doi: 10.1016/s0147-9563(96)80046-x.
7
Heparin-induced thrombocytopenia and thrombosis syndrome after cardiopulmonary bypass.体外循环后肝素诱导的血小板减少症和血栓形成综合征
Am J Crit Care. 2000 Jul;9(4):276-8.
8
Ancrod infusion for anticoagulation during and after PTCA in a patient with heparin-induced thrombocytopenia.安克洛酶输注用于肝素诱导的血小板减少症患者PTCA术中及术后的抗凝治疗。
Cathet Cardiovasc Diagn. 1994 Jul;32(3):286-7. doi: 10.1002/ccd.1810320320.
9
Heparinless cardiopulmonary bypass with ancrod.使用安克洛酶的无肝素体外循环
Ann Thorac Surg. 1994 Jun;57(6):1656-8. doi: 10.1016/0003-4975(94)90148-1.
10
Emergent cardiopulmonary bypass in five patients with heparin-induced thrombocytopenia type II employing recombinant hirudin.5例Ⅱ型肝素诱导的血小板减少症患者使用重组水蛭素进行紧急体外循环。
Anesthesiology. 1998 Sep;89(3):777-80. doi: 10.1097/00000542-199809000-00029.
引用本文的文献
1
Why is the platelet count low: should I be concerned about heparin-induced thrombocytopenia?血小板计数为何偏低：我应该担心肝素诱导的血小板减少症吗？
J Pediatr Pharmacol Ther. 2012 Jan;17(1):2-6. doi: 10.5863/1551-6776-17.1.2.
Zotero 插件